CHIARAMONTE, RAFFAELLA
 Distribuzione geografica
Continente #
EU - Europa 16.522
NA - Nord America 10.652
AS - Asia 10.056
SA - Sud America 860
AF - Africa 275
OC - Oceania 72
Continente sconosciuto - Info sul continente non disponibili 5
Totale 38.442
Nazione #
US - Stati Uniti d'America 10.273
GB - Regno Unito 5.395
DE - Germania 4.984
CN - Cina 3.662
SG - Singapore 2.795
IT - Italia 2.322
HK - Hong Kong 775
SE - Svezia 770
RU - Federazione Russa 714
VN - Vietnam 694
BR - Brasile 660
FR - Francia 533
BD - Bangladesh 480
NL - Olanda 453
IN - India 437
KR - Corea 291
CA - Canada 274
FI - Finlandia 252
IE - Irlanda 252
UA - Ucraina 231
TR - Turchia 200
DK - Danimarca 180
ID - Indonesia 156
JP - Giappone 134
CI - Costa d'Avorio 95
EU - Europa 81
EG - Egitto 79
BE - Belgio 71
AU - Australia 69
CO - Colombia 58
MX - Messico 52
PL - Polonia 52
TW - Taiwan 50
AR - Argentina 49
AT - Austria 47
ES - Italia 45
IQ - Iraq 45
PH - Filippine 45
IR - Iran 41
CH - Svizzera 39
ZA - Sudafrica 36
RO - Romania 35
GR - Grecia 32
MY - Malesia 32
EC - Ecuador 28
NO - Norvegia 24
CZ - Repubblica Ceca 23
PK - Pakistan 23
UZ - Uzbekistan 23
TH - Thailandia 21
JO - Giordania 19
SA - Arabia Saudita 19
VE - Venezuela 19
AE - Emirati Arabi Uniti 17
MA - Marocco 17
CL - Cile 16
NP - Nepal 16
IL - Israele 14
PY - Paraguay 13
HU - Ungheria 11
AZ - Azerbaigian 10
LT - Lituania 10
KE - Kenya 9
PT - Portogallo 9
TN - Tunisia 9
UY - Uruguay 9
CR - Costa Rica 8
DO - Repubblica Dominicana 8
DZ - Algeria 8
LU - Lussemburgo 8
HR - Croazia 7
LK - Sri Lanka 7
SC - Seychelles 7
KG - Kirghizistan 6
KW - Kuwait 6
PR - Porto Rico 6
BG - Bulgaria 5
NG - Nigeria 5
PS - Palestinian Territory 5
AL - Albania 4
BB - Barbados 4
HN - Honduras 4
MD - Moldavia 4
OM - Oman 4
PE - Perù 4
QA - Qatar 4
BN - Brunei Darussalam 3
CY - Cipro 3
GE - Georgia 3
GT - Guatemala 3
JM - Giamaica 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
LV - Lettonia 3
NZ - Nuova Zelanda 3
PA - Panama 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BA - Bosnia-Erzegovina 2
Totale 38.482
Città #
Southend 4.992
Frankfurt am Main 3.256
Singapore 1.670
Ashburn 1.365
Milan 919
Dallas 706
Hong Kong 688
Hanover 687
Beijing 620
Chandler 589
San Jose 573
Council Bluffs 360
Dearborn 346
Seattle 339
Wilmington 335
Fairfield 312
Ann Arbor 307
Princeton 298
Los Angeles 270
Dublin 244
New York 224
Santa Clara 219
Ho Chi Minh City 217
Woodbridge 199
Houston 189
Hanoi 185
Nanjing 173
Bengaluru 164
Lauterbourg 156
Cambridge 149
Helsinki 149
Boardman 143
Munich 137
Hefei 136
Guangzhou 135
Toronto 133
Jacksonville 130
Shanghai 130
Grafing 129
Mountain View 124
Buffalo 119
Jinan 112
Jakarta 107
Des Moines 105
Redmond 94
Rome 94
Abidjan 93
Moscow 93
The Dalles 92
Chaoyang 81
Phoenix 80
Serra 79
Shenyang 77
Columbus 75
Seoul 75
Tianjin 73
Tokyo 73
Cangzhou 69
Nanchang 66
Redwood City 66
Hangzhou 61
Brussels 59
Istanbul 56
Chicago 55
Changsha 54
Zhengzhou 54
Hebei 51
Medford 51
Naples 50
Sakarya 46
São Paulo 46
London 43
Andover 42
Da Nang 40
Berlin 38
Fuzhou 38
Ottawa 38
Basingstoke 37
Warsaw 37
San Diego 36
Bogotá 35
Nuremberg 34
Somerville 34
Atlanta 33
Amsterdam 32
Fremont 32
Mumbai 32
Ürümqi 32
Shenzhen 31
Wuhan 31
Rio de Janeiro 30
Eitensheim 29
Orem 29
Cairo 27
Washington 27
Haiphong 26
Vienna 26
Brooklyn 25
Montreal 25
Ningbo 25
Totale 25.347
Nome #
Multiple myeloma exploits Jagged1 and Jagged2 to promote intrinsic and bone marrow-dependent drug resistance 682
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 675
The impact of sex on ropporin expression in multiple myeloma patients 505
Oxidative stress signalling in the apoptosis of Jurkat T lymphocytes 470
Cancer testis antigen Sperm Protein 17 as a new target for triple negative breast cancer immunotherapy 464
A wide role for NOTCH1 signaling in acute leukemia 451
Extracellular vesicles mediate the communication between multiple myeloma and bone marrow microenvironment in a NOTCH dependent way 448
Notch regola recettori chemochinici che influenzano migrazione e proliferazione nella leucemia linfoblastica acuta a cellule T 421
Extracellular vesicles enhance multiple myeloma metastatic dissemination 404
Notch signaling deregulation in multiple myeloma : a rational molecular target 396
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu 394
Jagged blockade promotes tumor cells response to Bortezomib in a zebrafish model of multiple myeloma 384
Notch signaling promotes drug resistance in multiple myeloma through the regulation of the CXCR4/SDF1α axis 383
Re-establishing apoptosis competence in bone associated cancers via communicative reprogramming induced through notch signaling inhibition 361
Notch signalling in cancer 352
Expression Pattern and Biological Significance of the lncRNA ST3GAL6-AS1 in Multiple Myeloma 346
Nanoplastic impact on bone microenvironment: A snapshot from murine bone cells 342
Long non-coding RNA NEAT1 targeting impairs the DNA repair machinery and triggers anti-tumor activity in multiple myeloma 340
Nanoplastics & health: taking a picture of bone cells 339
Notch signaling drives multiple myeloma induced osteoclastogenesis 333
A new strategy of selective Notch receptor targeting in multiple myeloma based on small molecules 331
Multiple myeloma-derived Jagged ligands increases autocrine and paracrine interleukin-6 expression in bone marrow niche 330
Jagged1/2 inhibition promotes tumor cells response to Bortezomib in a zebrafish model of multiple myeloma 328
Anti-Notch treatment prevents multiple myeloma cells localization to the bone marrow via the chemokine system CXCR4/SDF-1 324
Inflammatory role of extracellular sphingolipids in Cystic Fibrosis 324
Jagged1/2 inhibition promotes multiple myeloma cell sensitivity to Bortezomib in vitro, ex-vivo and in vivo in a novel zebrafish model 319
Allele frequency of two intragenic microsatellite loci of SEL1L gene in Northern Italy population 316
Jagged ligands enhance the pro-angiogenic activity of multiple myeloma cells 314
Activation of long non-coding RNA NEAT1 leads to survival advantage of multiple myeloma cells by supporting a positive regulatory loop with DNA repair proteins 307
Notch1 produce una deregolazione dell’asse chemiochinico CXCR4/SDF1 nelle cellule di mieloma multiplo 306
Homotypic and Heterotypic Activation of the Notch Pathway in Multiple Myeloma-Enhanced Angiogenesis: A Novel Therapeutic Target? 305
Molecular events underlying interleukin-6 independence in a subclone of the CMA-03 multiple myeloma cell line 303
Sex Steroid Regulation of Oxidative Stress in Bone Cells: An In Vitro Study 300
AKT promotes the oncogenic Notch signaling in T-cell acute lymphoblastic leukemia 299
Notch signaling promotes bone marrow-induced drug resistance in multiple myeloma through the regulation of the CXCR4/CXCL12 system 298
Targeting Notch to induce anakoinosis in multiple myeloma niche 298
DIS3 depletion in multiple myeloma causes extensive perturbation in cell cycle progression and centrosome amplification 296
Interleukin-8 is a potential senescence inducer in lung fibroblasts 291
The Notch pathway in tumor cell migration 286
Targeting notch as a therapeutic approach for human malignancies 285
AKT regulation of oncogenic Notch pathway in T-cell acute lymphoblastic leukemia 285
Identification of small molecules uncoupling the Notch : Jagged interaction through an integrated high-throughput screening 277
Targeting tumor initiating cells through inhibition of cancer testis antigens and notch signaling : A hypothesis 274
Rational for molecular targeting the communication of multiple myeloma and bone marrow niche : why Notch? 274
Reciprocal regulation of Notch and PI3K/Akt signalling in T-ALL cells in vitro 273
A new therapeutic strategy in multiple myeloma based on small molecules directed to notch pathway 272
The role of notch pathway in multiple myeloma progression toward IL-6 independence 270
Multiple myeloma-associated drug resistance : targeting the Notch pathway 269
Notch targeting prevents multiple myeloma associated osteoclastogenesis 269
Bone marrow-mediated drug resistance is promoted by Jagged-induced notch pathway in multiple myeloma 266
Notch controlla la comunicazione mediata dalle chemochine nel microambiente tumorale 264
Notch-directed microenvironment reprogramming in myeloma : a single path to multiple outcomes 264
Alu-dependent RNA editing of GLI1 promotes malignant regeneration in multiple myeloma 263
Bone marrow-mediated drug resistance is promoted by Jagged-induced Notch signaling in multiple myeloma 262
Hypoxia increases multiple myeloma stem cells by modulating notch signalling 261
Resveratrol dependent apoptosis in T-acute lymphoblastic leukemia cell line MOLT-4 260
Notch-targeted therapeutic strategy in multiple myeloma based on small molecules hampering receptor-ligand interaction 259
Is Notch1 involved in the deregulation of molecular processes in T-ALL? 256
Targeting the Notch pathway in multiple myeloma through small molecules uncoupling Notch-Jag interaction 254
Jagged-induced notch signaling promotes endogenous and bone marrow-mediated drug resistance in multiple myeloma 254
Understanding the contribute of the notch pathway in multiple myeloma bone marrowniche : a focus on extracellular vesicles-mediated communicatio 254
Notch1 produces a deregulation of CXCR4/SDF1 chemokine signaling in Multiple Myeloma cells 253
The Notch pathway controls multiple myeloma crosstalk with the osteoclastogenic niche 252
The role of Notch in apoptosis : crosstalk with old and new pathways 245
Investigating the Impact of Epstein-Barr Virus on Sphingolipid Composition in Extracellular Vesicles of Multiple Sclerosis Patients 244
Notch pathway promotes multiple myeloma cell IL-6 independence 241
Notch1 oversignaling drives to deregulation of biological and molecular processes in T-ALL 239
Expression of Hes-1 (Notch-1 effector) during "In vitro" normal erythroid differentiation 237
Understanding the role of extracellular vesicles in the interaction of multiple myeloma with the surrounding microenvironment: the key contribution of the Notch pathway 237
T-ALL leukemogenesis: involvement of Notch and ras pathway in the regulation of apoptosis and cell cycle 236
A novel therapeutic approach targeted notch in multiple myeloma based on small molecules uncoupling receptor-ligand interaction 236
Multiple myeloma related angiogenesis: role of notch signaling pathway 234
Notch signaling and multiple myeloma: challenging endogenous and bone marrow-mediated drug resistance 233
Reduction of Movement in Neurological Diseases : Effects on Neural Stem Cells Characteristics 232
Effects of motor deprivation on neurogenesis 231
Notch Signal Transduction is not Regulated by Sel1L in Leukemia and Lymphoma Cells in culture. 229
AKT positively regulates Notch pathway in T-cell acute lymphoblastic leukemia 229
No evidence for SEL1L as a candidate gene for IDDM11-conferred susceptibility 229
Restoring Tissue Homeostasis at Metastatic Sites: A Focus on Extracellular Vesicles in Bone Metastasis 229
PI3K/AKT signaling inhibits NOTCH1 lysosome-mediated degradation 228
Multiple myeloma-endothelium: 2D and 3D systems to study notch signaling 227
Role of extrac ellular vesicles-mediated communication in the crosstalk between myeloma cells and the bone marrow niche 226
Targeting the interaction of multiple myeloma and the bone marrow microenvironment through novel small molecules directed to Notch pathway 225
The Potential of JAG Ligands as Therapeutic Targets and Predictive Biomarkers in Multiple Myeloma 224
Cooperation between Notch and CXCR4/SDF1a axis in ovarian cancer 221
Understanding the interaction of human cancer cells with the surrounding microenvironment: the new challenge in modern oncology 221
Burkitt lymphoma translocation turns Notch over to the dark side 220
Role of JAG1 and JAG2 ligands in promoting the angiogenic switch in multiple myeloma 220
Regulation of the human glut4 gene expression in tumor RD18 cell line 217
Resveratrol-induced apoptosis in human T-cell acute lymphoblastic leukaemia MOLT-4 cells 217
Differential regulation of Notch signal transduction in leukemia and lymphoma cell in culture. 215
Notch pathway and Interleukin-6 cooperate and support multiple myeloma cell growth 215
A novel Notch-targeted therapeutic approach in multiple myeloma based on small molecules disrupting Notch-Jagged interaction 215
Selective expression of the Sp17/AKAP4/PTTG1 in NSCLC for detection and therapy 215
Down-Regulation of Notch1 Expression is Involved in HL-60 Cell Growth Inhibition Induced by 4-Hydroxynonenal, a Product of Lipid Peroxidation 214
MOTILITY AND INVASIVE PROPERTIES OF LAM/TSC CELLS FROM CHYLOUS OF A LAM/TSC PATIENT 214
Notch pathway and Inteleukin-6 cooperate to support multiple myeloma cell proliferation 213
The notch ligands Jagged1 and 2 are a potential therapeutic target in multiple myeloma- associated bone disease 211
Differential modulation of matrix metalloproteinases-2 and-7 in LAM/TSC cells 211
Jagged-directed therapy in multiple myeloma: a new approach to interrupt the crosstalk between the tumor cell and the bone marrow microenvironment 209
Totale 29.074
Categoria #
all - tutte 97.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021148 0 0 0 0 0 0 0 0 0 0 0 148
2021/20222.938 241 117 194 177 157 218 234 191 296 253 432 428
2022/20232.489 259 213 287 208 361 455 47 167 291 38 117 46
2023/20243.927 66 111 137 185 489 119 518 413 244 437 577 631
2024/20256.571 566 726 455 751 436 242 237 517 321 621 554 1.145
2025/202610.829 1.127 910 1.211 871 1.021 726 1.461 423 948 727 1.175 229
Totale 39.813